'Stem cell tourism' growing trend: Panel decries overseas clinics that provide treatments devoid of scientific validity
Experts gathered at Harvard to discuss the growing trend of "stem cell tourism," which some believe diminishes the legitimacy of the scientific research being done. I. Glenn Cohen, an assistant professor at Harvard Law School, suggested that one way to slow stem cell tourism could be to prosecute for child abuse when the treatment involves minors. Credit: Scott Eisen/Harvard Staff Photographer
Internet sites offer help for people suffering from a dizzying array of serious conditions, including: Alzheimer's, Amyotrophic lateral sclerosis, atherosclerosis, autism, brain damage, cancer, cerebellar ataxia, cerebral palsy, chronic obstructive pulmonary disease, Crohn's, diabetes, diseases of the eye, genetic disorders, Huntington's, kidney disease, lupus, muscular sclerosis, muscular dystrophy, Parkinson's, rheumatoid arthritis, spinal cord injury, spinal muscular atrophy, stroke, and Tay-Sachs disease.
There are clinics all around the world—but especially in China, India, the Caribbean, Latin America, and nations of the former Soviet Union—that will provide stem cell treatments for those long-intractable conditions. Never mind that cancer is the only disease category on that list for which there is published, scientifically valid evidence showing that stem cell therapy may help. Thousands, if not tens of thousands, of desperate people are flocking to clinics that charge tens of thousands of dollars for every unproven treatment.
That "stem cell tourism" was the subject of a panel discussion titled "Stem Cell Therapy and Medical Tourism: Of Promise and Peril?" presented Wednesday by the Harvard Stem Cell Institute (HSCI) and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
Brock Reeve, HSCI executive director, introduced the topic by pointing out to those attending the session in Harvard Law School's Austin Hall that there is medical tourism, and then there is medical tourism. After all, Reeve noted, patients flock from all over the world to the Harvard-affiliated Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Center Institute, and other Boston research hospitals for cutting-edge, scientifically validated treatments for a host of diseases.
But then there is the other kind of medical tourism, and every member of the panel agreed with speaker Timothy A. Caulfield, the Canada Research chair in health, law, and policy at the University of Alberta, when he said that the stem cell tourism phenomenon "hurts the legitimacy of the entire field" of stem cell science and medicine.
While adult stem cells have been used for decades to treat a number of malignancies—bone marrow transplants are, in fact, blood stem cell transplants—those treatments, said George Q. Daley, the Samuel E. Lux IV Professor of Hematology/Oncology and director of the Stem Cell Transplantation Program at Children's Hospital Boston and Dana-Farber Cancer Institute, are the only stem cell treatments that are not experimental.
Daley, a member of the Harvard Stem Cell Institute's executive committee and past president of the International Society for Stem Cell Research, added that "we are seeing a growing number" of legitimate clinical trials, "but all such uses are experimental … and there is great skepticism as to whether we have" the scientific knowledge and basis even to "predict that these will be effective." It may, he said, take decades before there is certainty.
But the overseas clinics selling stem cell therapy for a sweeping catalog of diseases aren't offering patients places in clinical trials. They are touting what they claim are established treatments, with proven results. Caulfield and his colleagues in Alberta have conducted a number of studies on what is being offered at the overseas clinics, what claims are being made, who is seeking the treatments, and why. He said that the treatments are offered as safe, routine, and effective, but "none of what is being offered matched what the scientific literature said." He accused the clinics of "financial exploitation" of desperate people, and said those who raise money to finance pilgrimages to them are "raising money to turn over to a fraud."
I. Glenn Cohen, an assistant professor at Harvard Law School and co-director of the Petrie-Flom Center, suggested that one way to slow stem cell tourism could be to prosecute for child abuse when the treatment involves minors. "This falls under existing child-abuse and neglect statutes," Cohen said.
"I am sympathetic to parents" who believe they are helping their children, he said, suggesting that pediatricians in the United States should first try to convince parents to agree to the use of proven therapies, next try to dissuade them from using unproven therapies, then threaten to report them to the authorities, and, when all else fails, report them.
One member of the panel was at a far remove from stem cell research, patient treatment, and science.
So it came as little surprise that Jill Lepore, David Woods Kemper '41 Professor of American History and chair of Harvard's History and Literature Program, came at the issues from a very different perspective. "I don't have patients," Lepore said, "I have characters." She then proceeded to tell the story of Robert Ettinger, who for decades ran the Cryonics Institute outside Detroit, which offered its clients the hope of eternal life by freezing their brains after death until some future time when the condition that claimed their lives could be cured.
Lepore pointed out that the institute recently was reclassified a "cemetery" by the state of Michigan. She said there is a kind of "faith in science that draws" some people to any promise of a cure for disease, no matter how specious. What fuels this false hope, she said, is "one of the most dangerous elements of our culture: that we have forgotten how to die."
Provided by Harvard University
- Data doesn't back websites' stem-cell claims, says researcher Dec 08, 2008 | not rated yet | 0
- Nature reports on unapproved stem-cell therapies in China Apr 12, 2012 | not rated yet | 0
- Calif. institute budgets stem cell funds Oct 05, 2006 | not rated yet | 0
- Scientists create 20 disease-specific stem cell lines Aug 07, 2008 | not rated yet | 0
- Molecule dictates how stem cells travel Jan 14, 2006 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
Food microbiology laboratories continue to submit false negative results and false positive results on a routine basis. A retrospective study of nearly 40,000 proficiency test results over the past 14 years, presented today ...
Other 45 minutes ago | not rated yet | 0
Siemens has presented the world's first ultrasound system with wireless transducers. The system's transducers, which can be easily operated with one hand, transmit ultrasound images via radio waves to the ...
Other 5 hours ago | not rated yet | 0
(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.
Other May 18, 2013 | not rated yet | 0
(AP)—Medical marijuana use in Illinois is now in Gov. Pat Quinn's hands after the state Senate approved legislation.
Other May 17, 2013 | 5 / 5 (1) | 0
A Nigerian court on Friday sentenced two officials from a pharmaceutical company to seven years in prison over the sale of an adulterated teething drug which killed 84 babies in 2008.
Other May 17, 2013 | not rated yet | 0
57 minutes ago | not rated yet | 0 |
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
59 minutes ago | not rated yet | 0
As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug"—a prescription stimulant or amphetamine—to gain an academic edge. But a new University of Michigan poll shows only one in ...
21 minutes ago | not rated yet | 0
Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...
49 minutes ago | not rated yet | 0
National guidelines recommend that at-risk women be screened for elevated cholesterol levels to reduce their chances of developing cardiovascular disease. But who is 'at risk?' The results of a study by investigators ...
59 minutes ago | not rated yet | 0
Hospital emergency departments play a growing role in the U.S. health care system, accounting for a rising proportion of hospital admissions and serving increasingly as an advanced diagnostic center for primary care physicians, ...
22 minutes ago | not rated yet | 0